Article
A homogenizing process of selection has maintained an "ultra-slow" acetylation NAT2 variant in humans.
Human biology - 1 Jan 2014
Patillon B, Luisi P, Poloni E S, Boukouvala S, Darlu P, Genin E, Sabbagh A
Abstract excerpt
N-Acetyltransferase 2 (NAT2) is an important enzyme involved in the metabolism of a wide spectrum of naturally occurring xenobiotics, including therapeutic drugs and common environmental carcinogens. Extensive polymorphism in NAT2 gives rise to a wide interindividual variation in acetylation capacity, which influences individual susceptibility to various drug-induced adverse reactions and cancers. Striking...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
